|
Ischaemic heart disease
Citations 1-10 of 97 total displayed.
|
Most recent content
(1 Oct 2007):
|
- Therapeutics
Hormone therapy for younger women may not increase CHD risk during 5–7 years follow-up, but stroke risk was increased independent of age
- Robert L Reid
Evid Based Med 2007; 12: 137.
[Extract]
[Full text]
[ web only appendix ]
|
Past content
(since Jan 2000):
|
- Therapeutics
Percutaneous coronary intervention plus optimal medical therapy was not more effective than medical therapy alone in stable CAD
- Bertram Pitt
Evid Based Med 2007; 12: 107.
[Extract]
[Full text]
- Therapeutics
An intensive smoking cessation intervention reduced hospital admissions and mortality in high risk smokers with CVD
- Charles J Bentz
Evid Based Med 2007; 12: 113.
[Extract]
[Full text]
- Therapeutics
Stress echocardiography safely classified more patients as low risk of serious CAD than exercise electrocardiography
- Paul A Heidenreich
Evid Based Med 2007; 12: 119.
[Extract]
[Full text]
[ web only table ]
- Clinical prediction guide
Review: Framingham risk scores have variable accuracy in predicting CVD events in different patient populations
- Edward P Havranek
Evid Based Med 2007; 12: 87.
[Extract]
[Full text]
- Therapeutics
Review: high dose statins reduce risk of non-fatal cardiovascular events more than standard dose statins
- L Kristin Newby
Evid Based Med 2007; 12: 42.
[Extract]
[Full text]
- Therapeutics
Atorvastatin at 80 mg/day reduced cerebrovascular events more than atorvastatin at 10 mg/day in stable coronary heart disease
- Patrick O’Malley
Evid Based Med 2007; 12: 43.
[Extract]
[Full text]
- Therapeutics
Review: ß blockers differ in their efficacy for preventing major cardiovascular events in younger and older patients
- Robert Weiss
Evid Based Med 2006; 11: 168.
[Extract]
[Full text]
- Therapeutics
Review: selective COX 2 inhibitors increase vascular events more than placebo and naproxen but not more than other NSAIDs
- Andreas Laupacis
Evid Based Med 2006; 11: 171.
[Extract]
[Full text]
- Therapeutics
Raloxifene and tamoxifen had similar efficacy for preventing invasive breast cancer in women at increased risk
- Vered Stearns
Evid Based Med 2006; 11: 177.
[Extract]
[Full text]
[ web only table ]
|
|
